リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Can procalcitonin be used as a clinical biomarker during bacterial, viral and parasitic infections in dogs?」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Can procalcitonin be used as a clinical biomarker during bacterial, viral and parasitic infections in dogs?

Matur, Erdal Dokuzeylül, Banu Özcan, Mukaddes Çetinkaya, Handan Arslan, Murat Or, Erman Erhan, Songül Çötelioğlu, Ülker 北海道大学

2021.02

概要

The aim of this study is to investigate the usability of serum procalcitonin level in dogs as a clinical biomarker for the distinction between bacterial, viral, and parasitic diseases. A total of 160 dogs were used. The animals were evaluated in four groups as control and those with bacterial, viral, and parasitic infections. Serum procalcitonin, tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interferon-gamma (IFN-γ) level, and total white blood cell (WBC), and differential leukocyte count were determined. Serum procalcitonin level was found to be higher in dogs with bacterial infection compared to the control group and dogs with viral disease (P = 0.019). It was observed that serum procalcitonin level in dogs with bacterial infection varies related to the disease agent and it was found higher in those with pyometra (P = 0.009). Serum procalcitonin level was higher in dogs which had parasitic infections but, the difference is not significant. IL-6 level was found higher in dogs with viral and parasitic diseases than those in the control (P = 0.006). A negative correlation was determined between procalcitonin and IFN-γ (P = 0.001). While a positive correlation was detected between procalcitonin and WBC count, a negative correlation was determined between procalcitonin and monocyte percentage. In conclusion, serum procalcitonin level can be used as a clinical biomarker in bacterial diseases and, perhaps, in some parasitic diseases in dogs. However, further studies should be conducted to determine threshold values that take the severity of infection, its prevalence, and clinical course into account.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1) Aslan Ö, Demir M, Atay A, Köseoğlu MH, Kaya M. Correlation between procalcitonin and C-reactive protein levels. Turk J Biochem 9, 61-66, 2011.

2) Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36, 941-952, 2008.

3) Bec ze Z, M oln ár Z , Fazak as J. Can procalcitonin levels indicate the need for adjunctive therapies in sepsis? Int J Antimicrob Agents 46 Suppl 1, S13-18. 2015.

4) Brkljačić M, Brkljačić I, Torti M, Pleadin J, Mrljak V, Šmit I, Kiš I, Mayer I, Crnogaj M, Matijatko V. The concentrations of the inflammatory markers the amino-terminal portion of C-type pronatriuretic peptide and procalcitonin in canine babesiosis caused by Babesia canis. Vet Arhiv 84, 575-589, 2014.

5) Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20, 1-9, 2002.

6) Chiwakata CB, Manegold C, Bönicke L, Waase I, Jülch C, Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. Int J Infect Dis 183, 1161-1164, 2001.

7) Christ-Crain M, Müller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 30, 556-573, 2007.

8) Copp DH, Cheney B. Calcitonin-a hormone from the parathyroid which lowers the calcium-level of the blood. Natur, 193, 381- 382, 1962.

9) Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79, 1605- 1608, 1994.

10) Durnaś B, Wątek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, Góźdź S. Utility of blood procalcitonin concentration in the management of cancer patients with infections. Onco Targets Ther 22, 469-475, 2016.

11) Focà A, Liberto MC, Rametti L, Giancotti A, Marascio N, Quirino A, Caroleo S, Renzulli A, Matera G. Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients. Crit Care 16(Suppl 3), P43, 2012.

12) Giunti M, Peli A, Battilani M, Zacchini S, Militerno G, Otto CM. Evaluation of CALC-I gene (CALCA) expression in tissues of dogs with signs of the systemic inflammatory response syndrome. J Vet Emerg Crit Care 20, 523-527, 2010.

13) Goggs R, Milloway M, Troia R, Giunti M. Plasma procalcitonin concentrations are increased in dogs with sepsis. Vet Rec Open 12, 5, e000255, 2018.

14) Hagman R, Kindahl H, Fransson BA, Bergström A, Ström-Holst B, Lagerstedt AS. Differentiation between pyometra and cystic endometrial hyperplasia/mucometra in bitches by prostaglandin F2 alpha metabolite analysis. Theriogenol 66, 198-206, 2006.

15) Hagman R. Pyometra in small animals. Vet Clin North Am Small Anim Pract 48(4), 639- 661, 2018.

16) Hauptman JG, Walshaw R, Olivier NB. Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. Vet Surg 26, 393-397. 1997.

17) Jitpean S, Pettersson A, Odd V, Höglund OV, Holst BS, Olsson U, Hagman R. Increased concentrations of serum amyloid A in dogs with sepsis caused by pyometra. BMC Vet Res 10, 273, 2014.

18) Kuzi S, Aroch I, Peleg K, Karnieli O, Klement E, Dank G. Canine procalcitonin messenger RNA expression J Vet Diagn Invest 20, 629- 633, 2008.

19) Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med 28, 285-291, 2013.

20) Leli C, Ferranti M, Moretti A, Al-Dhahab ZS, Cenci E. Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Marker Article ID 701480, 2015.

21) Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Becker KL, Keller U, Müller B. In vitro and in vivo calcitonin-I gene expression in parenchymal cells: a novel product of human adipose tissue, Endocrinol 144, 5578-5584, 2003.

22) Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene- related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 32, 1715-1721, 2004.

23) Liu HH, Guo JB, Geng Y, Su L.Procalcitonin: present and future. Irish J Med Sci 184, 597- 605, 2015.

24) Magrini L, Gagliano G, Travaglino F, Vetrone F, Marino R, Cardelli P, Salerno G, Di Somma S. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department. Clin Chem Lab Med 52, 1465-1472, 2014.

25) Matur E, Eraslan E, Çötelioğlu Ü. Biology of procalcitonin and its potential role in veterinary medicine. J Ist Vet Sci 2, 16-27, 2017.

26) Meisner M. 1997. Procalcitonin - A new, innovative marker for severe infection and sepsis biochemical and clinical aspects. 2nd rev ed. Berlin, Germany: Brahms-Diagnostica.

27) Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, Moutardier V, Blache JL. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94, 767- 773, 2005.

28) Monneret G, Finck ME, Venet F, Debard AL, Bohé J, Bienvenu J, Lepape A. The anti- inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95, 193-198, 2004.

29) Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28, 977-983, 2000.

30) Pa sya r N, A lb orzi A , Poula d fa r GR . Evaluation of serum procalcitonin levels for diagnosis of secondary bacterial infections in visceral leishmaniasis patients. Am J Trop Med Hyg 86, 119-121, 2012.

31) Sant'Anna MC, Giordano LGP, Flaiban KKMC, Muller EE, Martins MIM. Prognostic markers of canine pyometra. Arq Bras Med Vet Zootec 66(6), 1711-1717, 2014.

32) Schouls LM, Van De Pol I, Rijpkema SG, Schot CS. Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella species in Dutch Ixodes ricinusticks. J Clin Microbiol 37, 2215-2222, 1999.

33) Troia R, Giunti M, Goggs R. Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis. BMC Vet Res 14:111, 1-9, 2018.

34) Walder G, Fuchs D, Sarcletti M, Berek K, Falkensammer B, Huber K, Petrovec M, Dierich MP, Würzner R. Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria. Int J Med Microbiol 296 Suppl 40, 297-301, 2006.

35) Whang KT, Vath SD, Becker KL, Snider RH, Nylen ES, Muller B, Li Q, Tamarkin L, White JC. Procalcitonin and proinflammatory Cytokine Interactions in Sepsis. Shock 14(1), 73-78, 2000.

36) Yılmaz Z, Ilcol YO, Ulus IH. Endotoxin increases plasma leptin and ghrelin levels in dogs. Crit Care Med 36, 828-833, 2008.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る